Skip to content
Screener

Thermo Fisher Scientific TMO Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Kewaunee Scientific Corporation logo
Kewaunee Scientific CorporationKEQU
$2.09M+17.1%
Danaher logo
DanaherDHR
$11M+37.5%
IQVIA logo
IQVIAIQV
$130M+1,525%
IR
Ingersoll RandIR
$65.7M-6.3%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$219.63B+25.8%
Enterprise value$254.75B+22.8%
P/E31.5×+5.0×
P/S4.9×-1.0×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions except share and per share amounts)March 28, 2026December 31, 2025
Capital in excess of par value18,71318,563
Retained earnings60,63259,156
Treasury stock at cost, 73,851,609 and 68,938,831 shares(25,360)(22,309)
Accumulated other comprehensive income/(loss)(2,497)(2,448)
Total Thermo Fisher Scientific Inc. shareholders’ equity51,93453,407
Noncontrolling interests77
Total equity51,94053,415
Total liabilities, redeemable noncontrolling interest and equity$113,281$110,343

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's noncontrolling interests in subsidiaries?
Thermo Fisher Scientific (TMO) reported noncontrolling interests in subsidiaries of $7M in Q1 2026.
How has Thermo Fisher Scientific's noncontrolling interests in subsidiaries changed year-over-year?
Thermo Fisher Scientific's noncontrolling interests in subsidiaries increased by 121.2% year-over-year, from -$33M to $7M.
What is the long-term trend for Thermo Fisher Scientific's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's noncontrolling interests in subsidiaries has grown at a -6.9% compound annual growth rate (CAGR), from $10M to $7M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Thermo Fisher Scientific's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude